scholarly journals Variation in the Amount of Hemoglobin S in a Patient with Sickle Cell Trait and Megaloblastic Anemia

Blood ◽  
1963 ◽  
Vol 21 (4) ◽  
pp. 479-483 ◽  
Author(s):  
PAUL HELLER ◽  
VINCENT J. YAKULIS ◽  
ROBERT B. EPSTEIN ◽  
SIGMUND FRIEDLAND

Abstract A patient with sickle cell trait and nutritional megaloblastic anemia was found to have a much smaller proportion of hemoglobin S during the megaloblastic phase than after recovery. This observation suggests preferential synthesis of hemoglobin A by megaloblastic bone marrow in the presence of the A-S trait.

Blood ◽  
1963 ◽  
Vol 22 (3) ◽  
pp. 334-341 ◽  
Author(s):  
RICHARD D. LEVERE ◽  
HERBERT C. LICHTMAN ◽  
Joan Levine

Abstract The relative rates of incorporation of Fe59 into heterogenic hemoglobins was studied in four patients with sickle cell trait. Three of the patients were free of superimposed disease, while one had active pulmonary tuberculosis. In all subjects there was a significantly greater incorporation of radioiron, per milligram of hemoglobin, into hemoglobin S than into hemoglobin A. The data indicate that in sickle cell trait the rates of synthesis of the heterogenic hemoglobins are not proportional to their circulating concentrations. Two interpretations appear possible. Since the size of the intra-marrow pool of hemoglobin S was not known, it is possible that there exists a smaller preformed pool of the abnormal hemoglobin, with the isotope making its appearance first in hemoglobin S. However, it is also possible that hemoglobin S is synthesized at a rate which is greater than that reflected by its circulating concentration. This implies that the relative concentrations of hemoglobin S and hemoglobin A vary from erythrocyte to erythrocyte, and that those cells with the greatest proportion of hemoglobin S are selectively destroyed.


Blood ◽  
1957 ◽  
Vol 12 (3) ◽  
pp. 238-250 ◽  
Author(s):  
H. C. SCHWARTZ ◽  
T. H. SPAET ◽  
W. W. ZUELZER ◽  
J. V. NEEL ◽  
A. R. ROBINSON ◽  
...  

Abstract 1. A Caucasian family is described in which, on the basis of clinical, hematologic and biochemical findings, it is postulated that the genes responsible for hemoglobins S and G and for the thalassemia defect are present. 2. On the basis of the study of this family, it is concluded that: a. The genes responsible for hemoglobins G and S cannot be alleles. b. The genes responsible for hemoglobin G and thalassemia cannot be alleles. c. The absence of hemoglobin A in individuals heterozygous for two "hemoglobin genes" does not provide critical evidence concerning the allelic relations of such genes. d. In this family, heterozygosity for the gene responsible for hemoglobin G results in an asymptomatic trait condition, in which some 40% of the hemoglobin is abnormal. When the gene responsible for G is combined with a hemoglobin S gene or a thalassemia gene, or both, the presence of hemoglobin G does not significantly alter the expression of these genes on their combinations. For example, an individual of the phenotype SG, whose hemoglobin contained no demonstrable A, was clinically a sickle cell trait, in that he showed no evidence of physiologic handicap. e. Individuals heterozygous for both the G and thalassemia genes may show on electrophoresis only hemoglobin G. This illustrates the unreliability in some cases of diagnosing genotype on the basis of electrophoretic findings. f. On the basis of these findings, hemoglobin G should probably be regarded as a normal variant of hemoglobin rather than as an abnormal type of hemoglobin.


2018 ◽  
Vol 50 (12) ◽  
pp. 2488-2493 ◽  
Author(s):  
BRYANT J. WEBBER ◽  
COLBY C. UPTEGRAFT ◽  
NATHANIEL S. NYE ◽  
Francis G. O’Connor

2012 ◽  
Vol 2012 ◽  
pp. 1-3 ◽  
Author(s):  
Donovan Calder ◽  
Maryse Etienne-Julan ◽  
Marc Romana ◽  
Naomi Watkins ◽  
Jennifer M. Knight-Madden

A patient who presented with sickle retinopathy and hemoglobin electrophoresis results compatible with sickle cell trait was found, on further investigation, to be a compound heterozygote with hemoglobin S and hemoglobin New York disease. This recently reported form of sickle cell disease was not previously known to cause retinopathy and surprisingly was observed in a non-Asian individual. The ophthalmological findings, the laboratory diagnosis, and possible pathophysiology of this disorder are discussed. Persons diagnosed with sickle cell trait who present with symptoms of sickle cell disease may benefit from specific screening for this variant.


Blood ◽  
1961 ◽  
Vol 17 (5) ◽  
pp. 610-617 ◽  
Author(s):  
DANIEL G. MILLER

Abstract The sickle cell trait appears to offer a reliable and replicable tag for bone marrow transplantation. Red cell survival curves using sickle cell and nonagglutinable cell counts show good agreement. The recipients exhibited no untoward effects as a result of receiving marrow from a donor with sickle cell trait.


1984 ◽  
Vol 16 (2) ◽  
pp. 123-127 ◽  
Author(s):  
Bruce F. Cameron ◽  
Diane B. Smith ◽  
Barbara Cody

1991 ◽  
Vol 325 (16) ◽  
pp. 1150-1154 ◽  
Author(s):  
H. Ewa Witkowska ◽  
Bertram H. Lubin ◽  
Yves Beuzard ◽  
Sylvain Baruchel ◽  
Dixie W. Esseltine ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document